$14.00
0[0.00%]
At close: Apr 24
$14.00
0[0.00%]
PreMarket: 4:20PM EDT
Sage Therapeutics
(NASDAQ:SAGE)Sage Therapeutics Stock (NASDAQ:SAGE), Earnings Estimates, EPS, and Revenue
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 25
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$86.5M
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | AM | SAGE | Q1 | -$2.46 | -$1.65 | — | — | $3.29M | $5.66M | — | — | Get Alert |
| 02/14/2024 | AM | SAGE | Q4 | -$2.47 | -$1.28 | -$0.55 | 57.03% | $2.87M | $60.98M | $77.97M | 27.86% | Get Alert |
| 11/07/2023 | AM | SAGE | Q3 | -$2.31 | -$2.73 | -$3.37 | -23.44% | $1.74M | $4.62M | $2.72M | -41.21% | Get Alert |
| 08/07/2023 | AM | SAGE | Q2 | -$2.13 | -$2.55 | -$2.68 | -5.10% | $1.50M | $2.94M | $2.47M | -15.85% | Get Alert |
| 05/02/2023 | AM | SAGE | Q1 | -$2.07 | -$2.50 | -$2.46 | 1.60% | $1.58M | $2.41M | $3.29M | 36.68% | Get Alert |
| 02/16/2023 | AM | SAGE | Q4 | -$2.12 | -$2.39 | -$2.47 | -3.35% | $1.64M | $1.94M | $2.87M | 47.68% | Get Alert |
| 11/08/2022 | AM | SAGE | Q3 | -$2.21 | -$2.21 | -$2.31 | -4.52% | $1.44M | $1.64M | $1.74M | 6.04% | Get Alert |
| 08/02/2022 | AM | SAGE | Q2 | -$1.83 | -$2.15 | -$2.13 | 0.93% | $1.64M | $1.76M | $1.50M | -14.72% | Get Alert |
| 05/03/2022 | AM | SAGE | Q1 | -$1.64 | -$2.04 | -$2.07 | -1.47% | $1.58M | $3.21M | $1.58M | -50.72% | Get Alert |
| 02/24/2022 | AM | SAGE | Q4 | $18.19 | -$2.17 | -$2.12 | 2.30% | $1.11B | $1.97M | $1.64M | -16.65% | Get Alert |
| 11/02/2021 | AM | SAGE | Q3 | -$2.03 | -$1.85 | -$2.21 | -19.46% | $1.64M | $1.96M | $1.44M | -26.53% | Get Alert |
| 08/03/2021 | AM | SAGE | Q2 | -$2.08 | -$1.69 | -$1.83 | -8.28% | $1.09M | $2.01M | $1.64M | -18.26% | Get Alert |
| 05/04/2021 | AM | SAGE | Q1 | -$2.44 | -$1.91 | -$1.64 | 14.14% | $2.29M | $2.00M | $1.58M | -20.85% | Get Alert |
| 02/24/2021 | AM | SAGE | Q4 | -$3.25 | -$0.35 | $18.19 | 5297.14% | $1.96M | $55.34M | $1.11M | -98.00% | Get Alert |
| 11/05/2020 | AM | SAGE | Q3 | -$3.48 | -$2.39 | -$2.03 | 15.06% | $3.57M | $1.86M | $1.64M | -11.88% | Get Alert |
| 08/10/2020 | AM | SAGE | Q2 | -$3.28 | -$2.66 | -$2.08 | 21.80% | $873.00K | $890.00K | $1.09M | 22.36% | Get Alert |
| 05/07/2020 | AM | SAGE | Q1 | -$3.37 | -$3.14 | -$2.44 | 22.29% | $465.00K | $2.80M | $2.29M | -18.36% | Get Alert |
| 02/27/2020 | AM | SAGE | Q4 | -$3.38 | -$3.61 | -$3.25 | 9.97% | $273.00K | $3.68M | $1.96M | -46.74% | Get Alert |
| 11/12/2019 | AM | SAGE | Q3 | -$2.63 | -$3.36 | -$3.48 | -3.57% | $0.00 | $3.60M | $3.57M | -0.83% | Get Alert |
FAQ
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics (SAGE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1.
What were the latest earnings per share (EPS) for Sage Therapeutics (NASDAQ:SAGE)?
Sage Therapeutics (SAGE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1 and the Actual EPS was $0.00, which beat the estimate of $-1.65.
What were Sage Therapeutics’s (NASDAQ:SAGE) revenues?
Sage Therapeutics (SAGE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on April 25, 2024 for Q1 and the Actual Revenue was $0K, which missed the estimate of $5.7M.
Browse earnings estimates, EPS, and revenue on all stocks.